Pacira Pharmaceuticals (PCRX) PT Lowered to $69 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $25.90 +0.54%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
H.C. Wainwright analyst Oren Livnat lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $69.00 (from $76.00) while maintaining a Buy rating.
You May Also Be Interested In
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Assembly Biosciences (ASMB) PT Lowered to $45 at Mizuho
- AutoZone (AZO) PT Lowered to $3,500; TD Cowen: 'Strong Execution But Not Immune To Industry DIY Headwinds'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
